MusclePharm Rentabilidad sobre recursos propios
¿Qué es el Rentabilidad sobre recursos propios de MusclePharm?
El Rentabilidad sobre recursos propios de MusclePharm Corp. es 60.99%
¿Cuál es la definición de Rentabilidad sobre recursos propios?
El rendimiento del capital es una medida de la rentabilidad de una empresa en relación con el valor contable del capital contable. Se calcula dividiendo los ingresos netos del año fiscal por el capital contable total.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Rentabilidad sobre recursos propios de compañías en Sector Consumer Staples en OTC en comparadas con MusclePharm
¿Qué hace MusclePharm?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Empresas con rentabilidad sobre recursos propios similar a MusclePharm
- ADVFN Plc tiene Rentabilidad sobre recursos propios de 60.62%
- Global Crossing Airlines tiene Rentabilidad sobre recursos propios de 60.68%
- Feishang Anthracite Resources tiene Rentabilidad sobre recursos propios de 60.72%
- Lilly(Eli) & Co tiene Rentabilidad sobre recursos propios de 60.72%
- Games Workshop Plc tiene Rentabilidad sobre recursos propios de 60.82%
- Kenon Ltd tiene Rentabilidad sobre recursos propios de 60.91%
- MusclePharm tiene Rentabilidad sobre recursos propios de 60.99%
- Emmaus Life Sciences Incorporation tiene Rentabilidad sobre recursos propios de 61.00%
- Origin Agritech tiene Rentabilidad sobre recursos propios de 61.11%
- BEST Inc tiene Rentabilidad sobre recursos propios de 61.11%
- Enzo Biochem tiene Rentabilidad sobre recursos propios de 61.16%
- PharmaSGP SE tiene Rentabilidad sobre recursos propios de 61.23%
- Sociedad Quimica Y Minera de Chile S.A tiene Rentabilidad sobre recursos propios de 61.39%